Gene Therapy Clinical Trials

The EMA approved the first gene therapy agent in 2012 – for lipoprotein lipase deficiency. Might gene therapies for ophthalmic disease reach the wards any time soon?

By Irv Arons and Mark Hillen

Related Articles